AGP Executive Report

Ukraine–Lithuania Talks: Ukrainian PM Serhii Koretskyi met Lithuania’s PM Mindaugas Sinkevičius in Lutsk to discuss continued support for Ukraine’s energy sector and businesses, including prospects for war-risk insurance, plus aid for veterans and reconstruction projects—especially in education and healthcare. Mental Health in Focus: Lithuania remains the EU leader in suicide mortality (18.8 per 100,000 in 2023), with Eurostat data also showing higher rates among men and older age groups; Belarus lacks public official figures, but published estimates still point to a high burden. Digital Safety for Kids: The European Commission is preparing plans to protect children from social media risks, with options including limits for under-13s or bans up to age 15, and possible parental consent for ages 13–15. Stroke Care Tech: XCath’s remote thrombectomy robot Iris received an FDA breakthrough designation after a remote telerobotic procedure in a living patient, aiming to expand access to mechanical thrombectomy. Local Health Infrastructure: Northway Biotech opened a €61M cell therapy and personalized medicine CDMO in Vilnius, positioning the Baltics for more advanced manufacturing capacity. Church Safeguarding: Lay activists renewed calls for an independent investigation into abuse in the Lithuanian Church after new criminal cases involving sexual offences against minors and related allegations.

Suicide Prevention: New Eurostat figures mark World Suicide Prevention Day with a drop in EU suicide mortality, but Lithuania still tops the bloc at 18.8 deaths per 100,000 in 2023, with men and older adults most affected. Mental Health & Workload: NB8 consular directors met in Tallinn to coordinate crisis evacuations and also discussed staff well-being, focusing on burnout signs and early support for diplomats and local mission teams. Local Health Innovation: Northway Biotech opened a €61M cell therapy and personalized medicine CDMO in Vilnius, aiming to speed up GMP-ready manufacturing for therapies and personalized processes. Medical Tech: XCath Robotics’ remote thrombectomy system Iris received an FDA breakthrough device designation after a remote procedure performed over 120 miles away, targeting unequal access to stroke care. Public Health Policy: The European Commission is weighing stronger rules to protect children from social media risks, with options including limits for under-13 or bans up to age 15. Health & Safety in Lithuania: Vilnius activists renewed calls for an independent investigation into child abuse in the Lithuanian Church after new criminal cases and priest suspensions.

Suicide Prevention Watch: New Eurostat figures for 2023 show Lithuania still leads the EU in suicide mortality (18.8 per 100,000), though the overall EU rate is falling for the third year in a row (10.4 per 100,000). Mental Health & Policy: The data also highlight big gaps by age and sex, with men accounting for most deaths and the rate highest among people 65+. Child Safety Online: The European Commission is set to propose new rules to protect children from social media risks, with options including limits for under-13 or a ban up to age 15, and parental consent for 13–15. Lithuanian Health Tech & Care Access: Northway Biotech opened a €61M cell therapy and personalized medicine CDMO in Vilnius, aiming to speed up GMP-ready manufacturing for advanced treatments. Medical Innovation: XCath’s remote thrombectomy robot Iris received an FDA breakthrough designation, following a remote procedure performed over 120 miles away. Local Health Governance: After new criminal cases involving abuse allegations in the Lithuanian Church, lay activists renewed calls for an independent commission to investigate how minors are protected. Public Health Research: Scientists used menstrual blood as a promising non-invasive route for diagnostics and regenerative medicine, including potential early cancer screening.

Suicide Prevention: New Eurostat data for World Suicide Prevention Day shows 48,370 suicides in the EU in 2023, with the standardized rate at 10.4 per 100,000—down from 2022 and below a decade ago; Mental Health in Lithuania: Lithuania recorded the highest suicide rate in the EU at 18.8 per 100,000, while men accounted for 76.4% of deaths; Local Health & Safety: Lithuania-linked church abuse cases are back in the spotlight after new criminal cases involving priests accused of sexual offences against minors, renewing calls for an independent investigation; Medical Innovation (Lithuania): Northway opened a €61M cell therapy and personalized medicine CDMO in Vilnius, aiming to support advanced manufacturing models for therapies; Stroke Care Tech: XCath’s remote thrombectomy robot Iris received an FDA breakthrough designation, potentially improving access to mechanical thrombectomy; Public Health Research: Menstrual blood is being explored as a non-invasive diagnostic tool, including for cervical cancer screening and other conditions.

Suicide Prevention: New Eurostat figures for 2023 show 48,370 suicides across the EU, with the overall rate still falling below a decade ago. Public Health Focus (Lithuania): Lithuania recorded the highest suicide rate in the EU at 18.8 deaths per 100,000 people, while Cyprus (3.5) had the lowest. Mental Health (Demographics): Men accounted for 76.4% of deaths, and rates rose with age, peaking at 17.3 per 100,000 among people 65+. Local Health & Safety (Church Abuse): In Lithuania, calls for an independent investigation into abuse in the Lithuanian Church have intensified after new criminal cases involving priests accused of sexual offences against minors. Health Tech (Vilnius): Northway opened a €61M cell therapy and personalized medicine CDMO in Vilnius, aiming to support advanced manufacturing for therapies. Medical Innovation (Stroke Care): XCath’s remote thrombectomy robot Iris received FDA breakthrough device designation, following a remote procedure performed over 120 miles away. Wellness & Research: A Lithuanian ultra-endurance runner’s 30,303 km challenge is being used as a rare case study on how extreme running affects the body, including muscle, blood markers, gut microbiome and cognition.

Breakthrough Stroke Care: XCath’s remote robotic-assisted system Iris has earned an FDA breakthrough device designation after performing the world’s first remote telerobotic mechanical thrombectomy in a living patient, operated from Panama to treat a case over 120 miles away—aiming to narrow global access gaps for specialist stroke treatment. Personalized Medicine in Lithuania: Northway Biotech is moving ahead with a major Vilnius expansion, opening a €61M cell therapy and personalized medicine CDMO, with multiple segregated cGMP lines designed to support tailored manufacturing. Mental Health & Public Health: Eurostat data for World Suicide Prevention Day shows suicide rates in the EU continue to fall, but Lithuania still records the highest rate in the bloc (18.8 per 100,000 in 2023). Church Safeguarding: New criminal cases involving sexual offences against minors have renewed calls for an independent investigation into abuse handling within the Lithuanian Church, as prosecutors and church authorities dispute when allegations were known. Innovation Watch: A Vilnius-based laser firm says compact femtosecond lasers could let robots do higher-value precision work, including medical manufacturing.

Northway Biotech in Vilnius: Lithuania’s Northway Biotech has opened a €61M cell therapy and personalised medicine centre, built for GMP manufacturing with multiple independent cGMP lines, quality labs and cleanroom capacity—aimed at scaling advanced therapies in the Baltics. New Tech for Precision Medicine: Lithuanian laser firm LITILIT says compact femtosecond lasers could upgrade industrial robots from basic handling to high-value precision work, including medical manufacturing. Mental Health in Crisis Response: NB8 consular directors met in Tallinn to coordinate emergency evacuations and discuss staff well-being, focusing on burnout signs and early support. Suicide Prevention Focus: Eurostat data for World Suicide Prevention Day shows 48,370 suicides in the EU in 2023, with Lithuania recording the highest rate in the bloc. Health & Costs Watch: Lithuania’s inflation hit 6.1% in August, with health costs up 4.9% year-on-year. Routes Europe 2028: Vilnius was selected to host Routes Europe 2028, a major air-connectivity forum expected to draw 1,000+ aviation decision-makers.

Suicide Prevention Focus: Eurostat data for World Suicide Prevention Day shows 48,370 suicides in the EU in 2023, with the overall rate falling below a decade ago; Lithuania recorded the highest rate in the bloc (18.8 per 100,000), while men accounted for most deaths (76.4%). Local Health & Research: A new line of research is using menstrual blood for non-invasive diagnostics and regenerative medicine, including potential cervical cancer screening and cartilage repair. Life Sciences in Lithuania: Northway Biotech opened a €61m cell therapy and personalised medicine centre in Vilnius, aiming to expand Baltic capacity for advanced therapies and regenerative medicine. Health Costs & Prices: Lithuania’s inflation accelerated in August to 6.1% year-on-year, with health costs up 4.9%—a reminder that medical spending pressures are rising. Aviation & Access: Vilnius was selected to host Routes Europe 2028, a move that could boost air connectivity and, indirectly, access to healthcare services and medical travel.

Northway Biotech’s Big Medical Leap: Northway Biotech opened a €61m cell therapy and personalised medicine CDMO centre in Vilnius, aiming to expand Lithuania’s advanced-therapy capacity with cGMP manufacturing lines and cleanroom infrastructure for autologous/allogeneic cell therapies and regenerative medicine. Local Health Costs Watch: Lithuania’s inflation climbed again in August, reaching 6.1% year-on-year, with sharp pressure from transport, housing and utilities—and health costs up 4.9%—while food prices fell. Cyber Resilience for Health & Critical Services: NRD Cyber Security says the Ukraine war and AI are reshaping cyber threats, pushing Baltic organisations to build resilience beyond traditional IT defenses, especially to keep critical services running during sustained attacks. EU Defence With Health Implications: EU states cleared a derogation for Ukraine to buy Patriot air-defence products, with the UK adding £100m, as Kyiv urges faster deliveries before winter after repeated missile and drone strikes. Life Sciences Industry Momentum: Staticus is investing €31.5m in an automated façade manufacturing hub in Vilnius with an integrated testing lab, part of a broader push toward automation and sustainability that can support healthier, lower-carbon building standards.

Northway Biotech Expansion: Northway Biotech opened a €61mn cell therapy and personalised medicine CDMO centre in Vilnius, adding cGMP manufacturing lines and cleanroom capacity for autologous/allogeneic cell therapies, regenerative medicine and personalised vaccines—aimed at boosting Lithuania’s life sciences growth. Public Health Costs: Lithuania’s inflation hit 6.1% in August, with health costs up 4.9% year-on-year, while transport and housing/utility costs also rose sharply—raising pressure on household budgets. Medical Imaging Breakthrough: Lithuanian researchers reported a deep-learning approach for “metabolically faithful” 3D PET restoration, aiming to improve clarity without distorting quantitative brain measurements used in neurodegenerative care. Disability Rights: The UN disability rights committee published findings covering Lithuania and other countries, urging stronger support systems and changes to how disability is handled in law and services. Cyber Resilience: Lithuania-based NRD Cyber Security says AI and Ukraine-driven lessons are reshaping cyber defence, pushing organisations to build resilience beyond traditional IT protection. Air Defence Support: EU states cleared a derogation for Ukraine to buy Patriot air-defence products, with the UK adding £100m—relevant for protecting hospitals and civilian life during attacks.

Northway Biotech Expansion: Lithuania’s Northway Biotech opened a €61m cell therapy and personalised medicine centre in Vilnius, adding a 3,500 sq m facility with cGMP manufacturing lines, quality labs and cleanroom infrastructure to support autologous/allogeneic therapies and regenerative medicine. Inflation Watch: Lithuania’s consumer prices accelerated to 6.1% year-on-year in August, with transport (+15.0%), housing and utilities (+15.8%) and health costs (+4.9%) driving the rise. Health Tech Research: Kaunas University of Technology researchers report a deep-learning method to restore 3D PET images while keeping metabolic measurements reliable—aimed at improving neuro disease imaging without distorting results. Life Sciences & Jobs: The new Northway site is positioned to grow Lithuania’s life sciences capacity, with plans to employ around 100 specialists and start with secured first customers. Cyber Resilience: NRD Cyber Security says AI is speeding up the cyber race, urging stronger resilience for critical infrastructure as Baltic states learn from Ukraine’s sustained attacks. EU Defence Support: EU states cleared a derogation for Ukraine to buy Patriot air-defence products, backed by a €3.2bn loan disbursement, while the UK adds £100m to speed deliveries before winter.

Biotech Investment: Northway Biotech opened a €61mn cell therapy and personalised medicine CDMO centre in Vilnius, a 3,500 sq m facility aimed at expanding Lithuania’s advanced therapy capacity with up to 20 cGMP manufacturing lines, quality labs and cleanroom infrastructure, starting with secured first customers and contracts. Public Health & Cost Pressures: Lithuania’s consumer price inflation climbed to 6.1% year-on-year in August, with health costs up 4.9% and transport, housing and utilities also rising sharply—while food prices fell 2.0%. Medical Research in Focus: A Lithuanian team reported a deep-learning approach to restore 3D PET scans while keeping metabolic measurements faithful, targeting more reliable imaging for neurodegenerative disease assessment. Healthcare Tech & Care Delivery: A study on asthma and type 2 diabetes highlights how obesity and inflammation link the two conditions, and points to incretin-based medicines as potential dual-benefit options for better asthma control. Vision Care Update: New clinical outcomes data on monofocal aspheric hydrophobic acrylic IOL implantation adds to the evidence base for cataract surgery lens performance and patient results.

New Cell Therapy Hub in Vilnius: Northway Biotech opened a €61m, 3,500 sq. m Innovative Cell Therapy and Personalized Medicine Center in Vilnius, expanding its CDMO capacity for gene therapy and other cell-based treatments, with cGMP manufacturing and first customer programs already lined up. Disability Rights Watch: The UN disability rights committee published findings urging Lithuania and other countries to improve protections for people with disabilities, including ending legal incapacity and substituted decision-making. Health Tech Research: Lithuanian researchers reported a deep-learning approach to restore 3D PET scans while keeping metabolic measurements reliable—aimed at better neurodegenerative disease assessment. Clinical Eye Care Study: A new prospective study assessed outcomes after implanting a monofocal aspheric hydrophobic acrylic IOL, adding to the evidence base for cataract surgery lens performance. Public Health & Policy Context: A US study links asthma plus type 2 diabetes to higher risk of asthma flare-ups, highlighting why weight and metabolic control matter for respiratory outcomes. Local Health System Planning: Lithuania is moving toward strategic hospital complexes in Vilnius and Kaunas for emergency care.

Innovative Cell Therapy in Vilnius: Northway Biotech opened a €61 million, 3,500 sq. m cell therapy and personalized medicine CDMO center in Vilnius, expanding cGMP capacity for gene therapy, autologous/allogeneic cell treatments, personalized vaccines, regenerative medicine and 3D tissue tech, with segregated manufacturing to support multiple products in parallel. Hospital Resilience Planning: Lithuania is moving to create fortified hospital complexes in Vilnius and Kaunas for emergencies, including surgery centers, secure critical-care facilities and dual-purpose spaces designed to keep healthcare running during wartime or crises. Medical Imaging Breakthrough: Researchers at Kaunas University of Technology reported a deep-learning approach for metabolically faithful 3D PET restoration, aiming to improve image clarity without distorting quantitative metabolic measurements. Asthma + Diabetes Drug Comparison: A US multicenter retrospective study examined whether tirzepatide vs semaglutide is linked to asthma exacerbation risk in patients with asthma and type 2 diabetes. Public Health Policy Watch: Lithuania is among countries where kratom sales are restricted or banned, as more jurisdictions tighten rules amid concerns about severe medical emergencies. Ukraine-EU Defense Cooperation: Petro Poroshenko met EU Defense and Space Commissioner Andrius Kubilius, pushing for stronger air defense and preparations for a Ukraine-EU drone alliance. Lithuania in the EU spotlight: The UN General Assembly backed a “Correct the Map” resolution supported by the African Union and India, aiming for more realistic world map proportions.

Lithuanian Healthcare Infrastructure: Lithuania is planning fortified hospital upgrades for crisis care, including a surgery center and dual-purpose car park at Kaunas Clinics, a convertible underground secure space at Santaros Clinics in Vilnius, and a fortified critical-situations medical center with operating rooms and hundreds of beds at RVUL—built with Israeli health and security input. Medical Imaging Breakthrough: Researchers at Kaunas University of Technology report “metabolically faithful” 3D PET restoration using deep learning (volumetric Swin transformers), aiming to sharpen scans without distorting quantitative tracer measurements used in neurodegenerative disease assessment. Biotech & Personalized Medicine: Northway Biotech opened a €61m cell therapy and personalized medicine CDMO center in Vilnius, adding cGMP manufacturing capacity for autologous/allogeneic cell therapies, gene therapy, personalized vaccines, and regenerative medicine. Public Health & Safety: An inquest heard a pedestrian killed on Lithuania’s A47 was not seen by the lorry driver, with post-mortem findings pointing to fatal head trauma. Drug Policy Watch: Lithuania is among countries where kratom sales are banned, as new restrictions and enforcement actions continue to spread internationally.

Medical Tech in Lithuania: Kaunas University of Technology researchers report a new deep-learning method for metabolically faithful 3D PET restoration, aiming to sharpen scans without changing the quantitative readings doctors use. Healthcare Capacity in Wartime: Lithuania is planning fortified, dual-purpose hospital infrastructure in Kaunas and Vilnius, including secure surgery and critical-care centres, with designs informed by Israeli health and security experts. Local Biotech Boost: Northway Biotech opened a €61m cell therapy and personalized medicine CDMO in Vilnius, adding cGMP manufacturing capacity for autologous/allogeneic cell therapies and other advanced treatments. Eye Surgery Outcomes: A new prospective feasibility study reviews 12-month visual and clinical results after implanting a monofocal aspheric hydrophobic acrylic IOL, focusing on post-op optical quality. Public Health Policy: Lithuania is among countries that have banned kratom, as more jurisdictions move to restrict or regulate the substance amid concerns about severe medical emergencies. Health & Safety in the Region: A Lithuanian-linked border case in Belarus involved hash oil hidden in vape devices on a passenger bus, with a medical exam confirming drug use.